ViaLase CEO talks innovations in glaucoma treatment

Conferences|ASCRS

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

See more ASCRS coverage

Related Videos
View All
Related Content

Eyenuk gets greenlight to market AI screening system in European Union

January 31st 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

Glaucoma surgical device lowers IOP level

January 30th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

Study: Atropine drops after glaucoma surgery may impair vision, prolong rehabilitation

January 26th 2023

Glaucoma 360: Innovation taking center stage

January 24th 2023

Eyenuk gets greenlight to market AI screening system in European Union

January 31st 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

Glaucoma surgical device lowers IOP level

January 30th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

Study: Atropine drops after glaucoma surgery may impair vision, prolong rehabilitation

January 26th 2023

Glaucoma 360: Innovation taking center stage

January 24th 2023

Eyenuk gets greenlight to market AI screening system in European Union

January 31st 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

Glaucoma surgical device lowers IOP level

January 30th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

Study: Atropine drops after glaucoma surgery may impair vision, prolong rehabilitation

January 26th 2023

Glaucoma 360: Innovation taking center stage

January 24th 2023
Advertise
Privacy
Editorial
Terms and Conditions
Contact Us
Do Not Sell My Personal Information
Job Board
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.